TY - JOUR
T1 - Immunotherapy for Cancer
T2 - Strategies of Immunomodulation Therapy in Combination with Conventional Approaches
AU - Gupta, Tanvi
AU - Murtaza, Mohd
AU - Ghosh, Mrinmoy
AU - Su, Wen Pin
AU - Pandey, Narendra Kumar
AU - Goutam, Umesh
N1 - Publisher Copyright:
© 2022 by Eurasian Journal of Medicine and Oncology-Available online at www.ejmo.org.
PY - 2022
Y1 - 2022
N2 - The disease that poses a major threat to human life is cancer. Although different treatment techniques such as che-motherapy, radiotherapy, and chemically driven drugs are used, they do not show expected results and cause many side effects, eventually leading to the death of patients. However, there is one approach that is promising is the consolidation of cancer vaccines and immunotherapy, in which tumor-specific antigens, tumor-associated antigens, antigen-presenting cells, and toll-like receptors play a major role. The approach involves vaccines that are approved by the FDA and has shown good results in the latest research studies.
AB - The disease that poses a major threat to human life is cancer. Although different treatment techniques such as che-motherapy, radiotherapy, and chemically driven drugs are used, they do not show expected results and cause many side effects, eventually leading to the death of patients. However, there is one approach that is promising is the consolidation of cancer vaccines and immunotherapy, in which tumor-specific antigens, tumor-associated antigens, antigen-presenting cells, and toll-like receptors play a major role. The approach involves vaccines that are approved by the FDA and has shown good results in the latest research studies.
UR - http://www.scopus.com/inward/record.url?scp=85127180561&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127180561&partnerID=8YFLogxK
U2 - 10.14744/ejmo.2022.51601
DO - 10.14744/ejmo.2022.51601
M3 - Review article
AN - SCOPUS:85127180561
SN - 2587-2400
VL - 6
SP - 1
EP - 11
JO - Eurasian Journal of Medicine and Oncology
JF - Eurasian Journal of Medicine and Oncology
IS - 1
ER -